Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Herben VM"'
Autor:
Mirghani RA; Department of Clinical Toxicology, Central Laboratories & Blood Bank, King Fahad Medical City, Riyadh 11525, Kingdom of Saudi Arabia., Sayi J, Aklillu E, Allqvist A, Jande M, Wennerholm A, Eriksen J, Herben VM, Jones BC, Gustafsson LL, Bertilsson L
Publikováno v:
Pharmacogenetics and genomics [Pharmacogenet Genomics] 2006 Sep; Vol. 16 (9), pp. 637-45.
Autor:
Kerbusch T; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands. thomas_kerbusch@sandwich.pfizer.com, Groenewegen G, Mathôt RA, Herben VM, ten Bokkel Huinink WW, Swart M, Ambaum B, Rosing H, Jansen S, Voest EE, Beijnen JH, Schellens JH
Publikováno v:
British journal of cancer [Br J Cancer] 2004 Jun 14; Vol. 90 (12), pp. 2268-77.
Autor:
Herben VM; Slotervaart Hospital/The Netherlands Cancer Institute, Department of Pharmacy and Pharmacology, Amsterdam, The Netherlands., Schoemaker nE, Rosing H, van Zomeren DM, ten Bokkel Huinink WW, Dubbelman R, Hearn S, Schellens JH, Beijnen JH
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2002 Jul; Vol. 50 (1), pp. 59-64. Date of Electronic Publication: 2002 Apr 05.
Autor:
Schoemaker NE; Department of Medical Oncology, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. APNSC@SLZ.nl, Herben VM, de Jong LA, van Waardenburg RC, Pluim D, ten Bokkel Huinink WW, Beijnen JH, Schellens JH
Publikováno v:
Anti-cancer drugs [Anticancer Drugs] 2002 Jan; Vol. 13 (1), pp. 87-91.
Autor:
Kerbusch T; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Louwesweg 6, 1066 EC Amsterdam, The Netherlands. aptkr@slz.nl, Herben VM, Jeuken MJ, Ouwerkerk J, Keizer HJ, Beijnen JH
Publikováno v:
Biopharmaceutics & drug disposition [Biopharm Drug Dispos] 2001 Apr; Vol. 22 (3), pp. 99-108.
Autor:
Herben VM; Slotervaart Hospital/The Netherlands Cancer Institute, Department of Pharmacy and Pharmacology, Amsterdam., Rosing H, ten Bokkel Huinink WW, van Zomeren DM, Batchelor D, Doyle E, Beusenberg FD, Beijnen JH, Schellens JH
Publikováno v:
British journal of cancer [Br J Cancer] 1999 Jul; Vol. 80 (9), pp. 1380-6.
Autor:
Herben VM; Department of Medical Oncology, Antoni van Leeuwenhoek Hospital/the Netherlands Cancer Institute, Amsterdam., van Gijn R, Schellens JH, Schot M, Lieverst J, Hillebrand MJ, Schoemaker NE, Porro MG, Beijnen JH, ten Bokkel Huinink WW
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 1999 Jun; Vol. 17 (6), pp. 1906-14.
Autor:
Herben VM; Department of Medical Oncology, Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute, and Department of Pharmacy and Pharmacology, Slotervaart Hospital/Netherlands Cancer Institute, Amsterdam, the Netherlands. apvhe@slz.nl, Schellens JH, Swart M, Gruia G, Vernillet L, Beijnen JH, ten Bokkel Huinink WW
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 1999 Jun; Vol. 17 (6), pp. 1897-905.
Autor:
Tuk B; Leiden/Amsterdam Center for Drug Research, Division of Pharmacology, Leiden, The Netherlands., van Oostenbruggen MF, Herben VM, Mandema JW, Danhof M
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 1999 May; Vol. 289 (2), pp. 1067-74.
Autor:
Herben VM; Department of Medical Oncology and Gynecology, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam. apvhe@slz.nl, Panday VR, Richel DJ, Schellens JH, van der Vange N, Rosing H, Beusenberg FD, Hearn S, Doyle E, Beijnen JH, ten Bokkel Huinink WW
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 1999 Mar; Vol. 17 (3), pp. 747-55.